...which helped pay for the Lancet study, Gilead Sciences Inc
• Pharma News
Powered By DaylifeOther company news pages:
- Abbott Labs
- Amgen
- AstraZeneca
- Bristol-Myers Squibb
- Eli Lilly
- Glaxo
- Roche
- J&J
- Merck
- Novartis
- Pfizer
- Sanofi-Aventis
- Schering-Plough
- Wyeth
Bristol-Myers Squibb Company News
Drugs add 13 years to average life of HIV patient
Democrats see drugmaker windfall from Medicare
...over $500 million in additional revenues from sales of its anti-psychotic medicine Risperdal through Medicare, and Bristol-Myers Squibb made an additional $200 million from its anti-clotting drug Plavix. The Republican committee members released their own...
Stocks head for mixed open ahead of housing data
...second-quarter reports were streaming in, including results from Ford Motor Co., Dow Chemical Co., Bristol-Myers Squibb Co., Eli Lilly & Co. and 3M Corp. Dow Jones industrial average futures fell 33, or 0.21 percent, to 11,580. The blue chip index rose nearly...
Bristol-Myers Squibb posts 8 percent profit jump
...N.J. - Drugmaker Bristol-Myers Squibb Co. on Thursday reported an 8 percent increase in second-quarter profit, beating Wall Street expectations, as the weak dollar boosted foreign sales and several key drugs saw big jumps in U.S. sales. Shares rose more than...
Biotech Stocks: Drug stocks edge higher, but Glaxo slides after strategy update
...markets. See full story. Glaxo made the announcement after it released a lackluster second-quarter earnings report. Bristol-Myers Squibb (BMY: , , ) and Eli Lilly & Co. (LLY: , , ) both released their second-quarter earnings reports before market open...
New Study Launched To Identify Best Practices in Inventing and Improving Virtual Collaboration Approaches
... MWH Global Inc. The St.Paul Companies Index Companies Mentioned: - Boehringer Ingelheim Pharmaceuticals Inc. - Bristol-Myers Squibb Co. - Cisco Systems Inc. - MWH Global Inc. - The St.Paul Companies For more information visit www.researchandmarkets.com/research/c30388/virtual_collaborat....
Bristol comes out swinging at Lilly clot drug
... NEW YORK (Reuters) - Bristol-Myers Squibb Co , which sells leading blood clot preventer Plavix, on Thursday dismissed Eli Lilly and Co's rival Effient drug as a "niche" product that has harmed or failed to help three groups of patients in...
Stocks fall after sales of existing homes decline
...big loss, and Dow Chemical Co., which said higher costs for raw materials sent earnings down sharply. But drug makers Bristol-Myers Squibb Co. and Eli Lilly & Co. both reported higher earnings as the weak dollar boosted foreign sales, and Amazon.com Inc. turned...
Why not jail-time?
...that money is headed back. California is supposed to receive $23 million of a $515 million nationwide settlement with Bristol-Myers Squibb. The California Department of Justice says that the settlement resolves allegations that the company reported âgrossly...
Bristol Profit Beats Forecasts, Helped by Plavix
...Squibb on Thursday posted quarterly earnings that beat forecasts, helped by higher sales of blood clot preventer Plavix and schizophrenia treatment Abilify, and the company announced an additional $1 billion in planned cost cuts. The New York-based drugmaker...
Clear
Clear